CEO Frédéric Desdouits finished up the week nicely with a visit to our partners Vertex Pharmaceuticals Paris office, to spend some time exchanging with their France General Manager, Nicolas Renard. Bon weekend à tous! #globalcollaboration #celltherapy #innovation
TreeFrog Therapeutics’ Post
More Relevant Posts
-
ASSOCHAM is organizing a ‘Annual Pharma Summit’ themed “Positioning India as the Pharmaceutical Innovation Hub” to assimilate key expectations of the Indian Pharma industry to focus on Research and Development. The conclave would bring together experts from the Government, industry, think tanks and academia to deliberate on the need for increased investments in R&D, its long-term benefits to the economy, impediments that need to be addressed, and key recommendations to boost the overall growth of the sector. Apart from the Inaugural session and Pharma Awards, the conference would broadly cover two major themes for deliberation: · ‘PRIP (Promotion of Research and Innovation in Pharma MedTech Sector): India opportunities for investments’ · ‘Driving Business growth: Building a conducive ecosystem for Innovation and Product Development’. Seize the opportunity to be honored as one of India’s most acclaimed pharmaceutical companies. Join us as we celebrate the champions of healthcare innovation!!!!! #pharma #innovation #R&D #Healthcare
To view or add a comment, sign in
-
We're gearing up for Reuters Events: Pharma & Patient USA 2024 in Boston (Oct 15-16) and we're excited to share some thought-provoking discussions from Pharma USA. Here's a sneak peek at what you can learn >> https://bit.ly/3Lb6dX2 💊 Boost adherence, increase trial participation, and create exceptional outcomes by integrating patient perspectives from the outset. 🔍 Hear from Voters for Cures and PhRMA on the patient's perspective on biopharmaceutical innovation and the policies needed for a robust pipeline of new treatments. 🔹 Oracle shares tips on reducing trial burdens, enhancing participant recruitment/retention, and using AI for automated drug safety monitoring. 🌍 Novartis explores why health equity is a game-changer for improving outcomes in innovation, access, and patient care. 🤝 Ipsen, Nestlé Health Science, Ocugen, and Essence Patient Solutions discuss leveraging partnerships to foster a patient-first pharma culture. Join us in the journey towards a patient-centric future! #REPatientUSA #PatientCentricity #HealthcareInnovation
To view or add a comment, sign in
-
The #BHHPanel about “Pharma 4.0: Explorando las fronteras de la salud digital” at the stage of #BStartup by Banco Sabadell, focused on innovations in #digitalhealth, the transformation of the pharmaceutical supply chain, and how these companies are adopting advanced technologies to enhance efficiency and patient care. Discover the main takeaways of panelists Rosa-María López-Carneros of Boehringer Ingelheim, Marta Pedrosa of CINFA, Marta Solé of Accord Healthcare, Miren Taberna of Savana, and moderator Orlando Vergara. Curious about the upcoming panels of Barcelona Health Hub at #4YFN? Check it out here: https://lnkd.in/dwWiDYjc
To view or add a comment, sign in
-
What does the EU Pharma Package mean for your company? Will it "incentivize innovation and improve access to medicines," or will the reductions in marketing exclusivity, requirements to launch in all 27 EU markets within 2 years, and the revision of orphan status and incentives as well as the proposed definition of High Unmet Medical Need lead to a drop in valuations, make some business models un-investible, and reduce access to medicines for patients? This legislation will come into force one way or another, and will have a massive impact, including on your company. Is there scope to improve the legislation or is it already too late, and what does it mean for your company? Broadreach Global is proud to organize this important discussion session . Join us at BiotechGate Digital Partnering on February 27 - register for free for the partnering and the program sessions at https://lnkd.in/g6iUcxUS Katja Murray FTI Consulting Sally Shorthose Bird & Bird Mark Treherne Monument Therapeutics Antoine Mialhe Graham Combe Patrik Frei Conor Duffy
To view or add a comment, sign in
-
In the pharmaceutical industry, diversity plays a critical role in multiple ways, from ensuring broad representation in clinical trials to capturing a wider range of opinions and lived experiences for optimal decision-making. In this recent feature by Adrea Cope, MPH in PharmaTimes Media Ltd, learn how pharma stands to make significant gains from emphasizing diversity across leadership teams and patient populations, and why going beyond diversity is needed to create equity across pharma. Read the article here: https://lnkd.in/eD_xEp-p #Pharma #Equity #Diversity #DEI
To view or add a comment, sign in
-
Looking for a short read on the challenges of attracting investments, the unique strengths and the importance of sustainability and collaboration in the Belgian biopharma sector? Have a read on this round table discussion where industry leaders and advocates of the biopharmaceutical industry answer key questions and explain their view on the future of biopharma in Belgium. Personally I'm happy to see that patient centricity is becoming more important than ever, although there are also concerns around competitiveness, regulations and attraction of talent. 👉Download our roundtable paper to learn more about these exciting developments in biopharma now https://pwc.to/3UhmnSU 💡This whitepaper is the result of a round table discussion hosted by PwC Belgium with members of the HST group were. The HST Group - Health, Science and Technology Group is an alliance between GSK, Johnson & Johnson, Pfizer and UCB that works closely with other industry players, the government authorities and academia to position Belgium as a global leader in biopharma and healthcare. Together, they discuss challenges around current global and EU developments as well as what other countries and markets are doing to successfully advance in this innovative sector. Their insights and recommendations are invaluable for shaping the future of the Belgian healthcare ecosystem. #PwCBelgium #biopharma #HSTGroup #Healthcare
To view or add a comment, sign in
-
Aspiring Pharmaceutical Professional | B.Pharm Candidate | Certified in Central Sterile Service Department Assistant | Certified Medical Coder.
🌐 Exploring the Post-Corona Landscape in India: Embracing Resilience and Innovation 🇮🇳 As we navigate the evolving post-pandemic era, it's crucial for the pharmaceutical industry to unite in shaping a resilient healthcare future for India. 🌟 In this insightful presentation, I delve into the transformative opportunities and challenges that lie ahead. 🔬 From redefining supply chains to advancing digital healthcare solutions, the post-corona phase demands strategic collaboration and innovation. Let's discuss how the pharmaceutical sector can play a pivotal role in elevating healthcare standards and fostering a healthier, more resilient nation. Excited to connect with forward-thinking pharma companies for a constructive dialogue on shaping India's healthcare future! 💊🏥 #PostCorona #HealthcareInnovation #Pharmaceuticals #ResilientFuture 🚀
To view or add a comment, sign in
-
The latest Access to Medicine Foundation report, highlighted in a recent ed silverman STAT article, reveals an urgent issue affecting all global health efforts: pharmaceutical companies still fall short in widening access to life-saving medicines in #LMICs. While most major companies are now advancing some access methods, inconsistencies in measuring patient reach and transparency in reporting hinder progress. With millions of lives at stake, it's time for corporations to step up, prioritize equitable healthcare, and ensure essential treatments reach the most vulnerable. When companies make promises to their ESG investors, we must ensure they follow through with clear, measurable impact. #AccessToMedicines #GlobalHealth #PharmaAction #CSR #ESG #Insulin
To view or add a comment, sign in
-
🌟 The stage is set, the connections are waiting – are you ready? Since the AUTOMA+ 2024 is approaching, we are happy to announce that everything is prepared for the unforgettable event. The lists of participants are almost ready, and very soon pharma industry leaders will meet for two days of productive networking in Zurich. A variety of professionals along the entire pharmaceutical value chain have already confirmed their participation, among them: ✅ Top Management ✅ Digital Transformation & IT ✅ Technology Experts ✅ Data Experts ✅ Supply Chain Experts 🤝 Get efficient B2B meetings in just 3 steps: 1. Select the companies you need from the list of Congress participants. 2. Send the selected companies to your Personal manager. 3. Done! Wait for the start of the Congress and get ready for the meetings with industry leaders. 📌 Pharmaceutical Automation and Digitalisation Congress AUTOMA+ 2024 is happening on November 18-19 in Zurich, Switzerland. Learn more about the event and register ➡️ https://lnkd.in/dcUU_3cF #AUTOMAplus2024 #AUTOMAplusnews
To view or add a comment, sign in
-
Chief Executive Officer of Complementary Medicines Australia - the peak industry body representing a $6.2 billion industry | Public Affairs | Government Relations | Corporate Affairs | Communications | Media | Governance
The Complementary Medicines Australia Innovation Day 2024 is underway - proudly sponsored by Lipa Pharmaceuticals Limited. Innovation in product development has never been more crucial for our sector. It’s the driving force behind progress, differentiation, and ultimately, success. Today, we come together to nurture and champion that spirit of innovation. Our industry stands out on the global stage for many reasons, but perhaps none more so than our commitment to innovation excellence. As the landscape evolves, we find ourselves increasingly focused on the science behind our products. This year, that focus takes centre stage as we explore our Innovation Day theme - The Science of Self Care. This theme embodies our dedication to understanding, improving, and advancing complementary medicine through rigorous scientific research. It’s about harnessing the power of research, evidence, technology and expertise to elevate our products and practices to new heights. #CMAID24
To view or add a comment, sign in
19,054 followers
CEO @ TreeFrog Therapeutics | Revolutionizing Cell Therapies
3moThank you Nicolas Renard and the team for welcoming me, and getting to know better each other.